RSIP Vision
Private Company
Total funding raised: $8M
Overview
RSIP Vision is a specialized AI software and R&D services company focused exclusively on medical image analysis. It partners with medical device manufacturers to integrate field-tested, clinically proven AI capabilities into their products, accelerating development from concept to regulatory approval. The company has over two decades of collective experience, with applications in cardiology, orthopedics, surgery, and more, and is trusted by industry leaders. Its business model is based on providing custom development and proprietary software modules, positioning it as an enabling technology partner in the digital health ecosystem.
Technology Platform
A deep learning and computer vision platform specialized for medical image analysis across multiple modalities (CT, MRI, ultrasound, endoscopy, etc.). Capabilities include segmentation, registration, detection, classification, and real-time surgical video analysis, developed with clinical robustness and regulatory pathways in mind.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
RSIP Vision competes with other specialized medical AI software vendors (e.g., Arterys, Aidoc), internal R&D teams at large medtech companies, and general-purpose AI/cloud platforms from tech giants (Google, NVIDIA). Its differentiation lies in its deep, field-tested expertise across multiple clinical domains, a focus on integration into regulated medical devices, and a proven track record of taking projects from concept to clinical use.